• OPEN AN ACCOUNT
Indian Indices
Nifty
25,090.70 122.30
(0.49%)
Sensex
82,200.34 442.61
( 0.54%)
Bank Nifty
56,952.75 669.75
( 1.19%)
Nifty IT
37,031.75 -110.10
( -0.30%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
9,012.99 20.87
(0.23%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

PSP Projects Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540544
INE488V01015
304.9160395
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PSPPROJECT
57.34
3236.95
EPS(TTM)
Face Value()
Div & Yield %
14.24
10
0
 

india home loan ltd
Ishita Drugs & Industries Ltd - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2025
May 23,2025
Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March 2025 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 2. To consider and approve the Directors Report with the Annexure Corporate Governance Report Management Discussion and Analysis Report and Notice for convening the 32nd Annual General Meeting of the Company. 3. To consider the appointment of M/s Meenu Maheshwari & Associates Practicing Company Secretary as the Secretarial Auditor of the Company for the year 2025-26. 4. To consider the re-appointment of Mr. Arvind Sapkal [DIN: 08607096] for the further term of Five years as an Independent Non-Executive Director of the Company. 5. To consider the re-appointment of Internal Auditors of the Company for the year 2025-26. 6. To take on record Disclosure of Interest of Directors. 7. Any other matter with permission of the Chair.